Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has introduced Sartoclear Dynamics, a clarification system featuring new single-use technology for harvesting mammalian cell cultures with high cell densities.
The treatment market value for fibromyalgia across the seven major markets will reach $1.9...
Juno Therapeutics, a biopharmaceutical company focused on cancer treatment, announced today that...
The global treatment market value for prostate cancer will expand more than threefold by 2023.
Epigenomics AG today announced that the Company will receive an EU grant under the industrial leadership Horizon 2020 research and innovation program.
Mylan N.V. today announced that it has increased its offer to acquire the issued and to be issued shares of Perrigo.
Sartorius Stedim Biotech (SSB), an international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.
Innate Pharma SA has entered into a collaboration with Sanofi to apply site-specific conjugation technology to the development of new Antibody Drug Conjugate
Too-thin models, too much drinking, sexy cigarette packs: France's parliament is cracking down on all of these in a sweeping bill designed to improve public health and trim public health costs.
A 2011 law overhauling the German pharmaceutical industry will be the biggest impediment to growth in the sector over the next several years, according to a new report.
U.S. health regulators have questions about tobacco maker Swedish Match's bid to become the first to market a smokeless tobacco product as less harmful than cigarettes.
British Prime Minister David Cameron on Wednesday apologized to thousands of patients who were infected from contaminated blood during the 1970s and 1980s.
A German court has ruled that a prominent anti-vaccination advocate must pay a doctor 100,000 euros ($105,720) in prize money he had promised to anyone who could prove measles is a virus.
Johnson Matthey, a provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion and commissioning of new high containment facilities for potent product manufacture at its Edinburgh, UK site (Macfarlan Smith).
Pernix Ireland Limited has signed a definitive agreement to acquire the Zohydro ER franchise from Zogenix, Inc. The acquisition includes three extended release hydrocodone products, including an abuse-deterrent pipeline and all related intellectual property.
Pfizer has announced that the European Commission approved an expanded indication for the use of Prevenar 13 for the prevention of pneumonia caused by the 13 pneumococcal serotypes in the vaccine in adults aged 18 years and older.
Britain's GlaxoSmithKline PLC and Switzerland's Novartis AG have completed a three-part deal that will offer the British company's shareholders a 4 billion pound ($6.17 billion) windfall.
A German court sentenced a male nurse to life in prison on for killing patients with overdoses of heart medication that he confessed to administering because he enjoyed trying to revive them.
Catalent Pharma Solutions has announced several expanded capabilities within its European Clinical Supply Services network. The expansions have been implemented in response to increased customer demand for specialty clinical packaging, where the proportion of highly-potent or temperature-sensitive investigational medical products continues to increase.
Biota Pharmaceuticals has entered into a definitive agreement to acquire Anaconda Pharma, a privately-held biotechnology company based in Paris, France. Anaconda Pharma's lead candidate is AP611074, a patented, direct-acting antiviral in development.
The World Health Organization is urging Europe to step up measles vaccination efforts as countries report thousands of cases of the disease.
Jacobs Engineering Group has received a contract from Bristol-Myers Squibb Company to provide architectural and engineering services for a new large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland.
Alkermes has appointed Mark Namchuk, Ph.D., as Senior Vice President of Research, Pharmaceutical and Nonclinical Development. Dr. Namchuk will be responsible for advancing the company’s early-stage product pipeline.
Hospira today announced the launch of the first biosimilar monoclonal antibody (mAb), Inflectra (infliximab), in major European markets. Inflectra is licensed for the treatment of inflammatory conditions including rheumatoid arthritis (RA), psoriatic arthritis, ankylosing spondylitis, adult and paediatric Crohn's disease, adult and paediatric ulcerative colitis and plaque psoriasis.
Authorities in Berlin say a spike in measles infections has been traced to unvaccinated refugees but at least two measles cases appear to have come from the United States.
The company announced the overhaul of its HealthCare, CropScience and other operations in a letter sent to employees Wednesday, though it indicated specific decisions on what the company will look like next January haven't yet been made.
Edmond de Rothschild Investment Partners announced today that its BioDiscovery 3 portfolio company, GlycoVaxyn AG, a privately held specialist vaccine biopharmaceutical company, has been acquired by GlaxoSmithKline in an all-cash transaction valuing the company at approximately $212M.
The Republican governor and likely presidential contender had originally been scheduled to address the press three times during the final day of his three-day trip to the United Kingdom. Instead, the availabilities vanished from his schedule, which included lunch with the chancellor of the exchequer and a visit to the famous Globe Theatre.
- Page 1